Related references
Note: Only part of the references are listed.Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States
Sandra E. Talbird et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
2009 update in prevention, evaluation, and outpatient treatment of influenza
James M. Williams
CURRENT MEDICAL RESEARCH AND OPINION (2009)
H1N1 2009 influenza virus infection during pregnancy in the USA
Denise J. Jamieson et al.
LANCET (2009)
What does the value of modern medicine say about the $50,000 per Quality-Adjusted Life-Year decision rule?
R. Scott Braithwaite et al.
MEDICAL CARE (2008)
Influenza vaccination of recommended adult populations, US, 1989-2005
Pengjun Lu et al.
VACCINE (2008)
Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic
M. Ruby Siddiqui et al.
EMERGING INFECTIOUS DISEASES (2008)
Pandemic influenza and pregnant women
Sonja A. Rasmussen et al.
EMERGING INFECTIOUS DISEASES (2008)
Prevention and treatment of influenza in high-risk groups: Children, pregnant women, inununocompromised hosts, and nursing home residents
Richard J. Whitley et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Influenza and pregnant women: Hospitalization burden, United States, 1998-2002
Shanna Cox et al.
JOURNAL OF WOMENS HEALTH (2006)
Hospitalizations with respiratory illness among pregnant women during influenza season
Shanna Cox et al.
OBSTETRICS AND GYNECOLOGY (2006)
Antivirals for influenza in healthy adults: systematic review
T Jefferson et al.
LANCET (2006)
Post-exposure influenza prophylaxis with oseltamivir - Cost effectiveness and cost utility in families in the UK
B Sander et al.
PHARMACOECONOMICS (2006)
How sensitive are cost-effectiveness analyses to choice of parametric distributions?
SG Thompson et al.
MEDICAL DECISION MAKING (2005)
Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities
NA Risebrough et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
The effects of the 1918-1919 influenza pandemic on infant and child health in Derbyshire
A Reid
MEDICAL HISTORY (2005)
Antiviral agents for influenza - A comparison of cost-effectiveness data
LD Lynd et al.
PHARMACOECONOMICS (2005)
Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis
MB Rothberg et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Parametric modelling of cost data in medical studies
RM Nixon et al.
STATISTICS IN MEDICINE (2004)
Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season
TV Hartert et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Management of influenza in adults older than 65 years of age: Cost-effectiveness of rapid testing and antiviral therapy
MB Rothberg et al.
ANNALS OF INTERNAL MEDICINE (2003)
Cost-effectiveness of newer treatment strategies for influenza
KJ Smith et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults
PA Muennig et al.
CLINICAL INFECTIOUS DISEASES (2001)
Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study
WL Irving et al.
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2000)
One thousand health-related quality-of-life estimates
TO Tengs et al.
MEDICAL CARE (2000)
Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia
JA Mauskopf et al.
PHARMACOECONOMICS (2000)
Influenza virus neuraminidase inhibitors
LV Gubareva et al.
LANCET (2000)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Prevention and early treatment of influenza in healthy adults
V Demicheli et al.
VACCINE (2000)
Share Paper
